RSS

Ecstasy

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for 3,4-Methylenedioxymethamphetamine (MDMA) as a potential treatment (in combination with psychotherapy) for patients struggling with PTSD more

News